DEMOGRAPHIC DIFFERENCES BY AGE, BMI, GENDER AND ETHNICITY OF PHASE I AND PHASE II ENZYME ACTIVITIES IN CRYOPRESERVED HUMAN HEPATOCYTES

被引：0
|
作者：
Moeller, Timothy
Dennell, Stephen
Rose, Terrell
Watt, Carolyn
Sahi, Jasminder
机构：
来源：
DRUG METABOLISM REVIEWS | 2012年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [31] Phase I and phase II metabolic activities are retained in liver slices from mouse, rat, dog, monkey and human after cryopreservation
    Martignoni, M
    Monshouwer, M
    de Kanter, R
    Pezzetta, D
    Moscone, A
    Grossi, P
    TOXICOLOGY IN VITRO, 2004, 18 (01) : 121 - 128
  • [32] COMPARISON OF MOUSE AND HUMAN COLON TUMORS WITH REGARD TO PHASE-I AND PHASE-II DRUG-METABOLIZING ENZYME-SYSTEMS
    MASSAAD, L
    DEWAZIERS, I
    RIBRAG, V
    JANOT, F
    BEAUNE, PH
    MORIZET, J
    GOUYETTE, A
    CHABOT, GG
    CANCER RESEARCH, 1992, 52 (23) : 6567 - 6575
  • [33] COMPARISON OF HUMAN AND RHESUS-MONKEY IN-VITRO PHASE-I AND PHASE-II HEPATIC DRUG-METABOLISM ACTIVITIES
    STEVENS, JC
    SHIPLEY, LA
    CASHMAN, JR
    VANDENBRANDEN, M
    WRIGHTON, SA
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (05) : 753 - 760
  • [34] Effects of L-proline on phase I and phase II xenobiotic biotransformation capacities of rat and human hepatocytes in long-term collagen gel cultures
    Beken, S
    De Smet, K
    Depreter, M
    Roels, F
    Vercruysse, A
    Rogiers, V
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2001, 29 (01): : 35 - 53
  • [35] An evaluation of race, ethnicity, age, and sex-based representation in phase I to II renal cell carcinoma clinical trials in the United States
    Kaldany, Alain
    Blum, Kyle A.
    Paulucci, David J.
    Beksac, Alp Tuna
    Jayaratna, Isuru
    Sfakianos, John P.
    Badani, Ketan K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 363.e1 - 363.e6
  • [36] Alteration in phase I and II enzyme activities and polycyclic aromatic hydrocarbons-DNA adduct formation by plant phenolics in mouse epidermis
    Szaefer, H
    Cichocki, M
    Brauze, D
    Baer-Dubowska, W
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2004, 48 (01): : 70 - 77
  • [37] Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II:: Results of a phase I/II clinical trial
    Amalfitano, A
    Bengur, AR
    Morse, RP
    Majure, JM
    Case, LE
    Veerling, DL
    Mackey, J
    Kishnani, P
    Smith, W
    McVie-Wylie, A
    Sullivan, JA
    Hoganson, GE
    Phillips, JA
    Schaefer, GB
    Charrow, J
    Ware, RE
    Bossen, EH
    Chen, YT
    GENETICS IN MEDICINE, 2001, 3 (02) : 132 - 138
  • [38] CHANGES IN SOME HEPATIC ENZYME-ACTIVITIES RELATED TO PHASE-II DRUG-METABOLISM IN MALE AND FEMALE RATS AS A FUNCTION OF AGE
    SANTAMARIA, C
    MACHADO, A
    MECHANISMS OF AGEING AND DEVELOPMENT, 1988, 44 (02) : 115 - 125
  • [39] Role of long non-coding RNA in DEET- and fipronil-mediated alteration of transcripts associated with Phase I and Phase II xenobiotic metabolism in human primary hepatocytes
    Lawrie, Roger D.
    Mitchell, Robert D., III
    Dhammi, Anirudh
    Wallace, Andrew
    Hodgson, Ernest
    Roe, R. Michael
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2020, 167
  • [40] A rapid and reduced cell demanding test for screening of the effects of test compounds on phase I and II activities in Plateable Human CryoHeps
    Alexandre, E.
    Baze, A.
    Desbans, C.
    Parmentier, C.
    Heyd, B.
    Mantion, G.
    Weber, J. C.
    Bachellier, P.
    Richert, L.
    Richert, L.
    TOXICOLOGY LETTERS, 2010, 196 : S144 - S144
12345